Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1353 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-06-22

Study Completion Date

2022-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Hospital-acquired venous thromboembolism (HA-VTE) is one of the leading preventable causes of in-hospital mortality, but prevention of VTE in hospitalized medical patients remains challenging, as preventive measures such as pharmacological thromboprophylaxis (TPX) need to be tailored to individual thrombotic risk.

The broad objective of this project is to improve VTE prevention strategies in hospitalized medical patients by prospectively examining VTE risk factors (including mobility) and comparing existing risk assessment models.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevention of Venous Thromboembolism Disease in Emergency Departments

NCT01212393

Quality of Health Care

COMPLETED

Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital

NCT01851239

Venous Thromboembolism

COMPLETED

Electronic Alert System for Improving Thromboprophylaxis in Hospitalized Medical Patients

NCT03124017

Venous Thromboembolism

COMPLETED NA

Explicit Assessment of Thromboembolic Risk and Prophylaxis for Medical Patients in Switzerland

NCT01277536

Venous Thromboembolism

COMPLETED

Effectiveness of Interventions for Hospital Medical Thromboprophylaxis: a Bicentric Swiss Quality-improvement Study

NCT05306821

Venous Thromboembolism

UNKNOWN NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Thromboembolism Venous Thromboses Pulmonary Embolism Deep Vein Thrombosis Embolism and Thrombosis Mobility Limitation Hospital Acquired Condition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 years
* Admitted for hospitalization \>24 hours on a general internal medicine ward
* Informed consent as documented by signature

Exclusion Criteria

* Need for therapeutic anticoagulation (e.g., atrial fibrillation)
* Life expectancy \<30 days
* Insufficient proficiency of the German or French language
* Unwilling to provide informed consent
* Prior enrolment in the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No